naltrexone vs semaglutide (GLP-1) and Low-Dose for Weight Loss Semaglutide + Naltrexone: Clinical Evidence
Description
GLP-1 medications were originally developed to treat type 2 diabetes, but several drugs in this class later received FDA approval for chronic weight management and obesity treatment
How long does semaglutide-induced fatigue last
Connectivity predicts deep brain stimulation outcome in Parkinson disease
But the science is pointing in an intriguing direction
Informed consent and ethical approval Informed consent was obtained from the patient and ethical approval was obtained from the Human Research Ethics Committee (MF2058-2024-1067)
Researchers can develop screening or diagnostic tools and design targeted treatment and prevention strategies by elucidating the underlying mechanisms and exploring antidiabetic approaches to alleviate the burden of diabetes-related cognitive dysfunction
